Volver a Agenda
Session Chair(s)
Gary L. Steinman, MS
President
Medexetech LLC, United States
Learning Objective : Identify and evaluate protocol features that drive up study conduct costs and/or impede timely study completion while adding little value to test article development; Design protocols that avoid such unnecessarily costly and challenging features and specifications; Consider the potential value of incorporating translational medicine methodologies in early phase 1 protocols.
Speaker(s)
Jazz, Tetris and CPUs: An Introduction
Gary L. Steinman, MS
Medexetech LLC, United States
President
Designing and Executing Efficient Phase 1 Protocols: Clinical Aspects
William B. Smith, MD
Alliance for Multispecialty Research, LLC , United States
CEO
Designing and Executing Efficient Phase 1 Protocols: Operations Aspects
Mary L. Westrick, PHD
University of Wisconsin, United States
Adjunct Professor
¿Tiene una cuenta?